BACKGROUND: Trauma causes a release of catecholamines, transforming growth factor-beta (TGF-beta), and T-helper II cytokines (TH2). Individually, these substances also induce arginase in macrophages. The purpose of this study was to determine the synergistic interactions between isoproterenol, TGF-beta, and TH2 cytokines on arginase expression in macrophages. METHODS: Confluent RAW 264.7 macrophages were incubated with various combinations of interleukins 4, 10, and 13 (IL-4, IL-10, IL-13), and TGF-beta with isoproterenol over 48 hours. Arginase activity, as well as arginase I expression by Western blot and reverse transcriptase-polymerase chain reaction, were measured. RESULTS: Although isoproterenol, IL-4, IL-10, and IL-13 individually induced arginase, significant synergy between the combination of isoproterenol with either TGF-beta or the TH2 cytokines was observed. All cytokines except IL-10 also induced arginase I protein and mRNA. Arginase II protein was detected in cells exposed to IL-10. CONCLUSIONS: We conclude that isoproterenol synergizes with IL-4, IL-13, and TGF-beta to increase arginase I mRNA and protein, as well as arginase activity in RAW 264.7 macrophages. Further, IL-10 synergizes with isoproterenol to increase arginase activity and arginase II protein. These synergistic mechanisms may compete with nitric oxide synthase for l-arginine substrate, thus shunting away available arginine from nitric oxide production and contributing to cellular immunosuppression observed after trauma.
BACKGROUND:Trauma causes a release of catecholamines, transforming growth factor-beta (TGF-beta), and T-helper II cytokines (TH2). Individually, these substances also induce arginase in macrophages. The purpose of this study was to determine the synergistic interactions between isoproterenol, TGF-beta, and TH2 cytokines on arginase expression in macrophages. METHODS: Confluent RAW 264.7 macrophages were incubated with various combinations of interleukins 4, 10, and 13 (IL-4, IL-10, IL-13), and TGF-beta with isoproterenol over 48 hours. Arginase activity, as well as arginase I expression by Western blot and reverse transcriptase-polymerase chain reaction, were measured. RESULTS: Although isoproterenol, IL-4, IL-10, and IL-13 individually induced arginase, significant synergy between the combination of isoproterenol with either TGF-beta or the TH2 cytokines was observed. All cytokines except IL-10 also induced arginase I protein and mRNA. Arginase II protein was detected in cells exposed to IL-10. CONCLUSIONS: We conclude that isoproterenol synergizes with IL-4, IL-13, and TGF-beta to increase arginase I mRNA and protein, as well as arginase activity in RAW 264.7 macrophages. Further, IL-10 synergizes with isoproterenol to increase arginase activity and arginase II protein. These synergistic mechanisms may compete with nitric oxide synthase for l-arginine substrate, thus shunting away available arginine from nitric oxide production and contributing to cellular immunosuppression observed after trauma.
Authors: Livingstone Fultang; Laura D Gamble; Luciana Gneo; Andrea M Berry; Sharon A Egan; Fenna De Bie; Orli Yogev; Georgina L Eden; Sarah Booth; Samantha Brownhill; Ashley Vardon; Carmel M McConville; Paul N Cheng; Murray D Norris; Heather C Etchevers; Jayne Murray; David S Ziegler; Louis Chesler; Ronny Schmidt; Susan A Burchill; Michelle Haber; Carmela De Santo; Francis Mussai Journal: Cancer Res Date: 2018-12-13 Impact factor: 12.701
Authors: Vera Barra; Anne-Marie Kuhn; Andreas von Knethen; Andreas Weigert; Bernhard Brüne Journal: Cell Mol Life Sci Date: 2010-10-15 Impact factor: 9.261
Authors: Maria Letícia Baptista Salvadori; Pedro Kastein Faria da Cunha Bianchi; Luiz Henrique Gebrim; Renata Santos Silva; José Roberto Kfoury Journal: Med Oncol Date: 2015-10-06 Impact factor: 3.064
Authors: Maritza J Romero; Lin Yao; Supriya Sridhar; Anil Bhatta; Huijuan Dou; Ganesan Ramesh; Michael W Brands; David M Pollock; Ruth B Caldwell; Stephen D Cederbaum; C Alvin Head; Zsolt Bagi; Rudolf Lucas; Robert W Caldwell Journal: Front Immunol Date: 2013-12-24 Impact factor: 7.561